future profitability, page-2

Sure.....licences and brevagen will continue to drive revenues up, as will the sp (the latter is already occurring).

However, as for market cap of approx 70+ million which is also likely to increase (substantially) moving forward, don't forget about that 'little' Immunaid project.

In my opinion (and according to others in the field), a year from now, not only will Immunaid be the golden egg for GTG/GENE, it will be worth more than the total market cap of Genetic Technologies in its own right.

Watch this space !!